drugset / Trial / NCT06295692
A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate how effective JNJ-77242113 is in participants with generalized pustular psoriasis (GPP) or erythrodermic psoriasis (EP).
Timeline
- Start
- 2024-02-09
- Primary completion
- 2025-01-14
- Completion
- 2027-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icotrokinra | Peptide | — | Oral |